Cytotoxic activities of certain medicinal plants on different cancer cell lines by Uğur, D. et al.
222
ORIGINAL ARTICLE
©Turk J Pharm Sci, Published by Galenos Publishing House.
ÖZ
Amaç: Son yıllarda kanserin önlenmesi ve tedavisi için, farklı sınıfta fitokimyasal içerikleri ve daha az yan etkileri nedeniyle bitkilerin kullanımı 
oldukça önem kazanmaktadır. Bu çalışmada, Türkiye’nin Kars ilinden toplanan dört farklı tıbbi bitki türünün altı farklı kanser hücre hattı ve bir normal 
hücre hattı üzerindeki sitotoksik etkileri incelenmiştir. 
Gereç ve Yöntemler: Sitotoksik aktivite MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-dipenyltetrazolium bromide] yöntemiyle belirlenirken, apoptotik 
hücre ölümü akış sitometri ve kaspaz-3 analizleriyle tespit edilmiştir. 
Bulgular: Artemisia absinthium yaprak özütü A-549, CCC-221, K-562, MCF-7, PC-3 hücre hatları üzerinde anlamlı sitotoksik etki (≥%70) gösterirken, 
tohum özütü ise CCC-221, K-562, MCF-7, PC-3 hücreleri üzerinde anlamlı sitotoksik etki (≥%70) göstermiştir. Normal hücre hattı Beas-2B hücresine 
kıyasla, seçici sitotoksik aktivite yaprak özütüyle A-549 ve K-562 hücreleri üzerinde gözlenirken, tohum özütüyle K-562, MCF-7 ve PC-3 hücreleri 
üzerinde gözlenmiştir. Her iki özütün sitotoksisite seviyesi düşük konsantrasyonlarda zaman ve doza bağlı olarak değişmektedir. İlave olarak, 
Plantago major bitki özütüyle A-549 hücreleri üzerinde seçici sitotoksisite (%78) elde edilmiştir. Hyoscyamus niger ve Amaranthus retrosa özütlerinin 
sitotoksisite aktivitesinin %10 ve %30 olduğu gözlenmiştir. 
Sonuç: A. absinthium özütleri ve P. major tohum özütü gelecek çalışmalarda bazı kanser hücrelerinin sitotoksisitesi için tedavi edici ilaç geliştirilmesi 
potansiyeline sahiptirler.
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Objectives: In recent years, the use of plants for the prevention and treatment of cancer is gaining more attention due to their diverse range 
of phytochemical constituents and fewer adverse effects. In this study, four medicinal plant species from the Kars province of Turkey were 
investigated for their cytotoxic potential against six different cancer cell lines and one normal cell line. 
Materials and Methods: MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-dipenyltetrazolium bromide] assay was performed to assess cytotoxic activity and 
apoptotic effect was determined using flow cytometry and caspase-3 analyses. 
Results: Significant cytotoxicity (≥70%) was observed with the leaf extract of Artemisia absinthium on A-549, CCC-221, K-562, MCF-7, PC-3 cells, 
whereas seed extracts caused significant cytotoxicity (≥70%) on CCC-221, K-562, MCF-7, PC-3 cells. Selective cytotoxicity was obtained with 
leaf extract on A-549 and K-562 cells; and with seed extract on K-562, MCF-7 and PC-3 cells compared with normal Beas-2B cells. The levels 
of cytotoxicity for both extracts were time- and dose-dependent at lower concentrations. Moreover, selective cytotoxicity (78%) was detected on 
A-549 cells with the seed extract of Plantago major. Cytotoxicity of extracts from Hyoscyamus niger and Amaranthus retrosa ranged between 10% 
and 30%. 
Conclusion: A. absinthium extracts and P. major seed extract have potential for development as therapeutic agents for cytotoxicity on certain cancer 
cells following further investigation.
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INTRODUCTION
Cancer is the most common and lethal disease in the modern 
era.1 New strategies or compounds need to be discovered 
because most known cancer treatments have adverse effects 
and all tumors do not react in the same way to treatment. Plant-
based medicines have good potential as a primary source 
for chemotherapeutic drugs. Some of the currently-used 
chemotherapeutic agents such as paclitaxel for breast cancer, 
vinca alkaloids for leukemia, and flavopiridol for colorectal 
cancer were initially derived from plants.2-5 In addition, herbal 
products are still used as primary health care products in most 
third world countries.6 Accordingly, plants as herbal medicines 
are good sources to search for antitumor compounds.
Traditional studies of plants use two parts, subterranean and 
surterranean. While almost all subterranean parts of the plant 
consist of root, surterranean parts of the plant have the bark, 
leaves, flowers, and seeds. All of these are derived from shoot 
apical meristem, but they are highly differentiated and consist 
of different secondary metabolites in different compositions.7 
In addition, medical uses of such plants are also specific to 
different parts of the plant, or in some cases, highly specific 
to certain regions of some parts. Therefore, it is important 
to clarify the part of the plant to be used for the source of 
therapeutic agents.
Studies have demonstrated that most phytochemicals act by 
interfering with several cell-signaling pathways and lead to 
cell cycle arrest and/or differentiation induction, apart from 
their apoptosis-inducing potential.8 Apoptosis is a central event 
essential in the maintenance of tissue homeostasis for all 
organ systems in the human body.9 Suppression of apoptosis 
in carcinogenesis plays a central role in the development and 
progression of cancer. Tumor cells use a variety of molecular 
mechanisms to suppress apoptosis.10 Hence, induction of 
apoptosis in tumor cells is a specific therapeutic approach 
towards cancer chemotherapy. 
Artemisia species belong to the Asteraceae family and are widely 
distributed in Asia, Europe, and North America. Medicinal 
values of Artemisia species have been approved throughout 
the world. Pharmacologic studies of Artemisia annula indicated 
the presence of novel biologically active compounds such 
as monoterpenes, sequterpenes, lactones, flavonoids, and 
coumarins.11 The extracts of some Artemisia species have been 
reported to exhibit cytotoxic effects on breast cancer cells.12 
Moreover, Plantago species have been used against cancer 
and Gálvez et al.13 showed cytotoxic activities of luteolin-
7-0-beta-glucoside, a major flavonoid against human renal 
adenocarcinoma and human melanoma. In contrast to Artemisia 
and Plantago species, not much information is available 
for Hyoscyamus niger and Amaranthus retrosa on cytotoxic 
activities against cancer cells.
Turkey is at the cross section of three phytogeographic regions, 
and is therefore very rich in terms of biodiversity.14 More than 
12.000 species and sub-species are considered to be in the 
region and they are used medically, as well as in the form of 
food and feed.15-17 The Kars province in the Eastern region of 
Turkey has a tradition of using herbal medicine for a variety of 
diseases, from headaches to cancer.15 Artemisia species from 
other countries are established to be cytotoxic in cancer12,18; 
however, there are no reports on the cytotoxicity of other 
plants on cancer cells. Although the chemical composition 
and biologic activities of many plant species are known in 
the literature, the level and quality of compounds, as well as 
their biologic activities can change significantly according to 
geographic origin and growing conditions. Therefore, this is the 
first study to evaluate the anticancer activities of four medicinal 
plants from Kars, which has 1800 m altitude. Ethanolic extracts 
of these plant parts were examined for their cytotoxicity on six 
cancer cell lines and one normal cell line according to time and 
concentration as variables. Furthermore, the mechanism of 
cytotoxicity was analyzed for Artemisia absinthium on A-549 
cells using flow cytometry and a caspase-3 assay. 
MATERIALS AND METHODS
Cell lines and culture conditions
A-549 (human lung carcinoma), CCC-222 (human colorectal 
carcinoma), DU-145 (human prostatic carcinoma), MCF-7 
(human breast carcinoma), K-562 (human leukemic carcinoma), 
and PC-3 (human prostatic carcinoma) cell lines were procured 
originally from ATCC. All cell lines were maintained in RPMI 
1640 culture medium (Biochrom, Germany), supplemented 
with 10% fetal bovine serum (FBS) (FBS; Biochrom, Germany), 
penicillin (100 U/mL) and streptomycin sulphate (100 mg/mL) 
(Biochrom, Germany). Cells were incubated at 37°C in 5% CO2, 
95% air in a humidified incubator. 
Plant material
Four different plant species, A. absinthium L. (Asteraceae), H. 
niger L. (Solanaceae), A. retrosa L. (Amaranthaceae) and Plantago 
major L. (Plantaginaceae) were collected from Kafkas University 
Campus in July and authenticated by Dr. Fatma Güneş in the 
Botanic Laboratory. The herbarium numbers of plants are A. 
absinthium L. (FG 2562); A. retrosa L. (FG 2563); H. niger L. 
(FG 2564); P. major L. (FG 2565). These plants are deposited in 
Trakya University, Herbarium of Faculty of Pharmacy.
Plant extraction
The plant samples were air-dried under shade and milled to 
a powder using a porcelain muller. Powdered plant materials 
(10 g) were extracted with 100 mL of ethanol several times 
by shaking at 53.1-54.6°C until the color faded. The extracts 
were filtered and solvent was removed in a vacuum using a 
rotary evaporator at 42-43°C in an Erlenmeyer bulb. After that, 
extracts was lyophilized to give the crude dry extract in freeze-
dryer. The powdered crude extracts were stored at -20°C 
until used. All extracts were dissolved in 10% DMSO as stock 
solution and further dilutions were freshly prepared to achieve 
working solutions. 
MTT assay
The cytotoxic activity of plant extracts was determined using 
an MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-dipenyltetrazolium 
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bromide] assay (Applichem, USA). This assay detects the 
reduction of MTT by mitochondrial dehydrogenase to a blue 
formazan product, which reflects the function of mitochondria 
and cell viability.19 Exponentially growing cells at 2x104 cells/mL 
were plated in triplicate into 96-well plates (Greiner, Germany) 
in 200 µL of growth medium and incubated for 24 hr before 
the addition of extracts. Plant extracts were dissolved in 10% 
DMSO and added to the cell culture at a final concentration of 4 
mg/mL to be tested against six cell lines. Cells were incubated 
for 72 hr at 37°C in a 5% CO2 incubator. For the dose and time 
responsiveness of the cells, plant extracts were added at 0.1 
mg/mL, 0.2 mg/mL, 0.5 mg/mL, 1 mg/mL, and 2 mg/mL final 
concentrations, and incubated for 24, 48, and 72 hr. After that, 
10 µL of PBS containing 5 mg/mL MTT was added into each 
well. After 4 hr incubation, the medium was discarded and the 
formazan blue crystals that formed in the cells were dissolved 
in 100 µL DMSO. Reduced MTT was quantified by reading 
the absorbance at 540 nm on a microplate reader (Thermo 
Scientific Multiscan Spectrum). The cytotoxic effects of the 
tested extracts were determined by comparing the optical 
density of the treated cells against the optical density of the 
untreated cells. Cytotoxicity relative to controls was calculated 
using the following formula:
% Cytotoxicity = [(Ac-At)/Ac)] x 100 (17)
Where Ac and At are mean absorbance of the control wells and 
mean absorbance of test wells, respectively. 
Caspase-3 assay
Caspase-3 activity was determined using caspase-3 
colorimetric assay kit (Abcam, USA). This assay measures the 
amount of free p-nitroanilide (pNA) in the cell produced by the 
cleavage of DEVD-pNA bond by activated caspase-3 during 
apoptosis. The experiment was conducted in accordance with 
the manufacturer’s protocol. In brief, A549 cells were treated 
with 4 mg/mL of A. absinthium extract for 36 hr. After that, 
cells were trypsinized and centrifuged at 1100 g for 10 min. 
Cells were resuspended in 1 mL of cold PBS and centrifuged 
at 4000 g for 5 min at 4°C. In order to extract total protein, 
cell pellets were suspended and lysed with 100 µL of lysis 
buffer and incubated on ice for 10 min. The cell lysates were 
then centrifuged at 10.000 g for 1 min at 4°C. The protein 
concentration was measured using a Bradford assay. Then, 
200 µg protein from each sample was mixed with 50 µL of 
2x reaction buffer containing 10 mM DTT and 5 µL of 4 mM 
caspase-3 substrate (DEVD-pNA) and incubated at 37°C for 
4 h. The p-NA light emission was quantified using an ELISA 
plate reader at 405 nm. The fold increase in caspase-3 activity 
was determined by comparing the absorbance of p-NA from an 
apoptotic sample with an untreated control cells. 
Flow cytometry
A-549 cells were cultured in 6-well plates (5x105 cells/well) 
and treated with 0.25 mg/mL, 1 mg/mL, 2 mg/mL, and 4 mg/
mL concentrations for both A. absinthium leaf and seed for 24 
hr. After treatment, cells were washed with PBS, trypsinized, 
washed, and resuspended in binding buffer. Five microliters of 
propodium iodine (PI) and 5 µL Annexin-V-FITC were added. 
After incubation for 15 min in the dark, 500 µL of binding buffer 
was added and ten thousand cells per group were analyzed 
using flow cytometry (BD FACSCanto A, BD Biosciences, USA). 
To detect PI and AnnexinV-FITC, green solid state 488 laser was 
used for excitation. Filter configurations for PI and FITC were 
556/LP and 585/40, and 502/LP and 530/30, respectively.
Statistical analysis
Data were analyzed using the Microsoft Office Excel (2007) 
SPSS software package. Multiple comparisons of treatments 
were performed using one-way ANOVA and Student’s t-test. 
A difference was considered to have significance at *p<0.05, 
*p<0.01, and *p<0.005. Data are presented as mean ± standard 
deviation of three replicates.
RESULTS
Screening of cytotoxic effects of plant extracts on different cancer 
cell lines
Six different cancer cell lines were treated with 4 mg/mL leaf 
or seed extracts for 72 hr to distinguish the effectiveness of 
each part of the plant on cytotoxicity (Figure 1). The results 
indicated that A. absinthium extracts showed toxicity between 
40% and 87% on all cell lines, except DU-145 cells (Figure 1a, 
b). Unlike A. absinthium extracts, other extracts exhibited either 
cytotoxic or mitogenic effects depending on the cell lines. 
The least toxic extract was the A. retrosa seed, which showed 
25% cytotoxicity on DU-145 cells. In addition, leaf extract of A. 
retrosa was cytotoxic on DU-145 and K-562 cell lines by 22% 
and 28%, respectively (Figure 1e, f). With the exception of the H. 
niger seed extract, all extracts resulted in cytotoxicity between 
20% and 30% on DU-145 cells.
The most effective extracts on cytotoxicity of K-562 cell lines 
were A. absinthium leaf (86%) and A. retrosa leaf (28%). In 
addition, the highest cytotoxicity (78%) for A-549 cells was 
obtained from P. major seed extract (Figure 1h). Among the 
other plant extracts, P. major seed was the best extract for 
selective cytotoxicity on A-549 cancer cell lines because it did 
not cause cytotoxicity on the normal Beas-2B cell line. 
Two statistical analyses were performed to see if the effects of 
extracts on cell lines were significant compared with the control 
containing no extract (Table 1) and the normal cell line, Beas-2B 
(Table 2). The most significant cytotoxic effects were exhibited 
by A. absinthium leaf and seed extracts, and P. major seed 
extract (Table 1). To date, most chemotherapeutic agents do not 
distinguish between normal and cancer cell lines. In the interest 
of having less damage to normal cells after cancer therapy, it is 
important to discover plant extracts with selective cytotoxicity 
for cancer cells. Therefore, the cytotoxic effect of plant extracts 
on cancer cells were compared with that of normal Beas-2B 
cells. According to the statistical analysis, A. absinthium seed 
extracts caused significant cytotoxicity on K-562, MCF-7, and 
PC-3 cell lines (Table 2). In addition, significant cytotoxic 
effects compared with Beas-2B cells were observed with A. 
retrosa leaf extract on DU-145 and K-562 cell lines, and P. major 
seed extracts on A-549 and DU-145 cell lines.
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Time- and dose-dependence of cytotoxicity
After detecting significant cytotoxicity on A-549 and K562 
cell lines treated with A. absinthium leaf and seed extracts, we 
investigated how time of treatment with varying concentrations 
of extracts affected the cytotoxicity. Cells were treated with 
0.1, 0.2, 0.5, 1, 2, and 4 mg/mL extracts for 24, 48, and 72 hr. 
Extracts caused cytotoxicity in a different manner (Figure 
2). For example, leaf extract above 0.2 mg/mL concentration 
resulted in cytotoxicity between 60% and 70% on A-549 
cells on day 1, remained the same level on day 2, and was 
between 60% and 83% on day 3 (Figure 2a). A similar manner 
of cytotoxicity was observed with seed extracts (Figure 2b). 
In addition, the cytotoxic effects of seed and leaf extracts on 
K-562 cells were proportional with the duration of exposure 
and the concentration of the extract (Figure 2c, d).
Figure 1. Cytotoxicity of plant extracts on different cancer cell lines. Cells were treated with leaf or seed extracts of plants at 4 mg/mL concentration for 72 
hr. Cytotoxicity was determined using MTT assays and results expressed as percentages of cytotoxicity compared with untreated control. Data expressed 
as mean ± standard deviation, n=3
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In addition, the dose-dependence experiment of P. major seed 
extract was conducted on the cytotoxicity of the A-549 cell line. 
Cells were treated with 4 mg/mL seed extract for 72 hr. It was 
observed that the level of cytotoxicity was proportional with 
the increasing concentration of the extract and reached around 
40% at 2 mg/mL, and 73% at 4 mg/mL (Data not shown).
Flow cytometric analysis of cell death 
Cellular cytotoxicity can be accounted for by various cellular 
processes, the most common of which is cell death. Cell death 
is classified as necrosis, apoptosis, and autophagy. Apoptosis 
is planned cell death, whereas autophagy and necrosis are 
considered as sudden deaths and occur when cells are under 
extensive stress. In this present study, flow cytometric analysis 
was performed in order to confirm cell death after treatment of 
A-549 cells with different concentrations of A. absinthium leaf 
and seed extracts. The results indicated a difference between 
the cytotoxicities created by seeds and leaf extracts (Figure 3). 
At a lower concentration of 0.2 mg/mL, seed extracts had already 
killed around 25% of cells, whereas the leaf extract exhibited the 
same cytotoxicity as the control (Figure 3b, Table 3). It took up 
to 2 mg/mL concentration to show a different profile than the 
controls for the leaf extract (Figure 3d). For both extracts, the 
percentage of dead cells gradually peaked as the concentration 
of extract increased. At 4 mg/mL, leaf and seed extracts caused 
20% and 6% survival rates, respectively (Figure 3e, Table 3). As 
a result, seed extract seems to kill A-549 cells through apoptosis 
at a lower concentration than leaf extract (Figure 3c).
Investigation of apoptosis by caspase 3 assay 
Apoptosis occurs through a series of cleavages of serine 
proteases called caspases. That serial cleavage, which is 
called a caspase cascade, is present in both the external and 
internal apoptotic pathway. In both pathways, the last protease 
that executes cell death is caspase-3. Cleavage of the apoptotic 
substrate by activated caspase-3 is a good indicator of the 
presence of apoptosis. Therefore, after treatment of A-549 cells 
with A. absinthium leaf extract at 4 mg/mL, the amount of active 
caspase-3 was measured in cell lysate. After 36 hr of treatment, 
caspase-3 was demonstrated to be activated in the cells and was 
found 4.5-folds higher than in untreated cells (Figure 4).
DISCUSSION
Use of medicinal plants as an approach in the prevention and 
treatment of cancer has been followed for many years and 
many therapeutic plants with anticancer activity are reported in 
Table 1. Difference of cytotoxicity on treated cells compared with untreated controls
Beas-2B A-549 CCC-221 DU-145 K-562 MCF-7 PC-3
A. absinthium (leaf) *** *** *** (-) *** *** ***
A. absinthium (seed) * (-) *** (-) *** *** ***
H. niger (leaf) (-) (-) (-) * (-) (-) +++
H. niger (seed) (-) + (-) + (-) + ++
A. retrosa (leaf) + (-) (-) * *** (-) +
A. retrosa (seed) (-) + + ** + (-) +
P. major (leaf) + (-) (-) * (-) (-) (-)
P. major (seed) (-) *** (-) *** (-) ++ +++
*Means cytotoxicity with *p<0.05, **p<0.01, ***p<0.005
+Means mitogenecity with +p<0.05, ++p<0.01, +++p<0.005
–No significant difference 
Table 2. Difference of cytotoxicity on cells compared with normal cell line Beas-2B
A-549 CCC-221 DU-145 K-562 MCF-7 PC-3
A. absinthium (leaf) + (-) (-) *** (-) (-)
A. absinthium (seed) (-) (-) * *** *** ***
H. niger (leaf) * (-) *** * * (-)
H. niger (seed) (-) (-) *** * (-) (-)
A. retrosa (leaf) (-) + *** *** (-) +
A. retrosa (seed) (-) + *** + (-) (-)
P. major (leaf) (-) * *** *** *** **
P. major (seed) *** + *** ++ + +++
*Means cytotoxicity with *p<0.05, **p<0.01, ***p<0.005 
+Means mitogenecity with +p<0.05, ++p<0.01, +++p<0.005 
–No significant difference
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the literature.20,21 As the interest in organic and simple lifestyles 
grows, the interest in plant-based medicine also increases.13 
In addition, adverse effects and drug interactions are major 
restrictions in synthetic anticancer drugs; therefore, plants 
have been investigated across the world to exploit novel and 
potential sources of anticancer agents.
Previous studies on Artemisia species have shown medicinal 
properties such as antibacterial and anticancer effects. Many 
phytochemicals exert their cytotoxic effects by acting as cell 
cycle and apoptosis regulators, as well as anti-inflammatory 
agents.22 In this present study, ethanol extracts of different 
plant species were evaluated for their cytotoxic potentials on 
different cancer cell lines. Emami et al.23 studied the anticancer 
activity of five species of Artemisia (A. kulbadica, A. sieberi, A. 
turanica, A. santolina, and A. diffusa) against Hep2 and HepG2 
cell lines. The authors used extracts from aerial parts of each 
Figure 2. Time-based dose response curves of cancer cells. A-549 cells (a, b) or K-562 cells (c, d) were treated with leaf or seed extracts of A. absinthium 
at various concentrations
Data are expressed as mean ± standard deviation, n=3
----n----: 0.1 mg/mL, —n—: 0.2 mg/mL, ----▲----: 0.5 mg/mL, —▲— : 1 mg/mL, ----------: 2 mg/mL, ———: 5 mg/mL
Table 3. Detection of apoptosis with flow cytometric analysis 
Treatment (concentration) Necrosis (%) Late apoptosis (%) Live cells (%) Early apoptosis (%)
Untreated 1.8 9.1 87.5 1.50
A. absinthium leaf (0.2 mg/mL) 1.0 7.0 89.3 2.6
A. absinthium leaf (0.5 mg/mL) 1.1 5.9 87.8 5.2
A. absinthium leaf (2 mg/mL) 52.90 6.2 37.5 3.4
A. absinthium leaf (4 mg/mL) 47.70 23.2 21.0 8.1
Untreated 1.60 12.4 85.4 0.7
A. absinthium seed (0.2 mg/mL) 5.7 12.0 74.5 7.8
A. absinthium seed (1 mg/mL) 31.8 20.6 31.3 16.3
A. absinthium seed (2 mg/mL) 56.1 10.6 29.6 3.8
A. absinthium seed (4 mg/mL) 60.8 30.7 6.2 2.4
A-549 cells were treated with A. absinthium leaf or seed extract for 24 hr
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species at concentrations between 0.2 mg and 3.2 mg/mL. The 
minimum toxic dose of extracts from five species ranged from 
0.4 to 1.6 mg/mL. Therefore, we used A. absinthium extracts at 
4 mg/mL to screen the cytotoxic effect of the extracts. In order 
to determine the dose- and time-dependence of cytotoxicity, 
the extracts were used at five different concentrations starting 
from 4 mg/mL to 0.1 mg/mL. In vitro cytotoxicity of leaf or 
seed extracts of A. abshintium was observed on almost all cell 
lines examined, except DU-145 cells. The level of cytotoxicity 
on A-549 cells was time- and dose-dependent, especially for 
leaf or seed extracts at less than 0.5 mg/mL concentrations 
(Figure 2a, b). Extracts at more than 0.2 mg/mL concentrations 
caused cytotoxicity above 60% even on day one. It stayed at the 
same level on day two and reached to 82% by day three. These 
findings indicated that leaf or seed extracts of A. abshintium 
may be effective on cytotoxicity of A-549 cells in a dose- and 
time-dependent manner at less than 0.2 mg/mL concentrations.
In addition, the cytotoxic activity of methanol extracts from 
different parts of five Arthemisia species was evaluated 
by Gordanian et al.12. A. absinthium was found to have a 
greater cytotoxic effect on MCF-7 cells with a 50% inhibitory 
concentration (IC50) value of 221.5 µg/mL. They showed that a 
flower extract of A. absinthium was more cytotoxic than those 
of leaf, stem, and root extracts. Similarly, we found that seed 
extracts at less than 0.5 mg/mL concentrations were more 
effective with regards cytotoxicity on A-549 cells compared 
with that of leaf extracts, especially on day 1 and day 2 (Figure 
2a, b). In fact, flower and leaf extracts of some Artemisia 
species contain rich sources of artemisinin, a sesquiterpene 
lactone Mannan et al.24, and artemisinin caused in vitro and in 
vivo anticancer activities in a previous study.25
Gordanian et al.26 reported that the cytotoxic activity of methanol 
extract from different organs of A. absinthium at higher 
altitude was 20-30% higher as compared with those of lower 
altitudes. The type and level of secondary metabolites may 
vary in the same plant species based on different agroclimatic 
and geographic regions.27 Gordonian et al.12 showed that leaf 
extract of A. absinthium from Iran at 0.1 mg/mL resulted in 
30% cytotoxicity on MCF-7 cell lines, whereas we found 20% 
cytotoxicity on MCF-7 cells at the same concentration (data not 
shown). However, this could be due to different geographic 
regions for plant origins and consequently an accumulation 
of different secondary metabolites, or the use of different 
solvents for extraction because they used different fractions of 
Figure 3. Flow cytometric analysis of apoptosis. A-549 cells were treated 
with leaf or seed extracts of A. absinthium at various concentrations. 
Results showing cells in necrosis (Q1), late apoptosis (Q2), live cells (Q3) 
and early apoptosis (Q4), for control (a), 0.25 mg/mL (b), 0.5 (c), 2 mg/mL 
(d), 4 mg/mL (e)
Figure 4. The effects of A. absinthium leaf extract on caspase-3 activity in 
A-549 cells as detected using a colorimetric assay. Treatment of cells with 
A. absinthium leaf extract exhibited 4.5-fold higher OD values than untreated 
cells. Data expressed as mean ± standard deviation, n
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methanol extracts in cytotoxicity assays. In addition, the greater 
cytotoxicity (>60%) of the same plant extracts on other cancer 
cell lines exhibits cell type specificity of the extracts.
Ethanol extracts from A. absinthium leaf and seed were evaluated 
for apoptotic potential using flow cytometric analysis and 
caspase-3 activity on A-549 cells. According to our findings, 
extracts induced apoptosis, and total cell death increased in a 
concentration-dependent manner. In other words, treatment of 
cells with more toxic concentration of extracts caused apoptosis 
and killed cells undergoing apoptosis faster through necrosis. 
Investigation of Bad and Bcl-2 protein expression levels in a future 
study will elucidate the mechanism of apoptosis in all cells lines 
examined here because the balance between pro-apoptotic and 
anti-apoptotic proteins is vital for cell survival. In a previous study, 
a methanolic extract of A. absinthium inhibited cell proliferation 
through apoptosis by modulating Bcl-2 family proteins and the 
MEK/ERK pathway in MCF-7 and MDA-MB-231 cell lines.18 
P. major has been used as a remedy against stomachache, 
toothache, and inflammation in the Kars region.15 In addition, 
traditional use of P. major in the treatment of tumors was 
reviewed by Samuelsen28 and Haddadian et al.29; however, 
not much information is available for scientific validation and 
anticancer activities. In this present study, we investigated the 
cytotoxic effect of extracts obtained from leaf and seed of P. 
major. Seed extracts exhibited 78% and 28% cytotoxicity on 
A-549 and DU-145 cells, respectively. Even though the leaf 
extract did not cause cytotoxicity on A-549 cells, it gave rise to 
38% cytotoxicity against DU-145 cells.
Gálvez et al.13 examined methanolic extracts of P. major against 
three different cancer cell lines and reported that the extract 
was more effective on MCF-7 cells with an LC50 value of 207 
µg compared with renal adenocarcinoma (TK-10) and human 
melanoma (UACC-62) cell lines. Unlike the finding of Gálvez et 
al.13, ethanolic extract of leaf and seed did not cause cytotoxicity 
on the MCF-7 cell line in the present study. However, the seed 
extract induced proliferation of MCF-7 cells by 38%. The 
differential cytotoxic effect of seed or leaf extracts on a variety 
of cancer cell lines may depend on differences in the fatty acid, 
amino acid, phenolic, and flavonoid composition of leaf or seed 
extracts. Kobeasy et al.30 reported the differences in levels of 
these compounds in leaf and seed extracts of P. major.
Leaf and seed extract of A. retrosa exerted cytotoxic activity on 
DU-145 and K-562 cell lines. However, both extracts resulted in 
cell proliferation in other cell lines. Rajasekaran et al.31 reported 
antitumor effects of methanolic extracts from Amaranthus 
spirous on Hep2, HepG2, HT-29, and Hu7 cell lines. In addition, 
anticancer activity of H. niger extract has not yet been 
reported in the literature. However, some studies examined 
the antiinflammatory and analgesic activity of the plant. It 
has been shown that methanol extracts of H. niger inhibit the 
activity of monoamine oxidase and lower the cellular levels 
of OH produced by mitochondria32, which suggests that the 
extract prevents oxygen damage by controlling reactive oxygen 
species activity and therefore prevents apoptosis. In our study, 
the cytotoxic effects of leaf and seed extracts on cancer cell 
lines were variable. They caused a cytotoxic reaction in some 
cell lines but induced cell proliferation in others. The range of 
cytotoxicity of H. niger extracts changed between 7% and 30% 
on various cancer cell lines, suggesting that this plant does not 
contain anticancer compounds.
CONCLUSION 
Ethanolic leaf and seed extracts of A. absinthium showed 
significant anticancer activity against five different cancer 
cell lines. Antitumor activities of leaf extract on A-549 and 
K-562 cells, and seed extracts on K562, MCF-7, and PC-3 was 
found to be selective compared with the normal Beas-2B cell 
line. In addition, seed extracts of P. major caused significant 
and selective anticancer activity against A-549 and DU-145 
cell lines but not on the Beas-2B cells. Other plant extracts 
induced anticancer activity with various levels. Moreover, leaf 
or seed extract of the plant exhibited different effects on cells, 
suggesting that different parts of the plant may have different 
types and concentrations of secondary metabolites depending 
on the function of the plant part. In conclusion, use of crude 
ethanolic extracts enabled us to detect the anticancer potential 
of phytochemicals of medicinal plants from the Kars region 
of Turkey. Future studies will identify the level of chemical 
components of A. absinthium and P. major extracts responsible 
for anticancer activity and elucidate more detailed molecular 
mechanisms of cell death.
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